Citation: Richard C Petersen. Free-radicals and advanced chemistries involved in cell membrane organization influence oxygen diffusion and pathology treatment[J]. AIMS Biophysics, 2017, 4(2): 240-283. doi: 10.3934/biophy.2017.2.240
[1] | Boel De Paepe . A recipe for myositis: nuclear factor κB and nuclear factor of activated T-cells transcription factor pathways spiced up by cytokines. AIMS Allergy and Immunology, 2017, 1(1): 31-42. doi: 10.3934/Allergy.2017.1.31 |
[2] | Ling Wang, Shunbin Ning . “Toll-free” pathways for production of type I interferons. AIMS Allergy and Immunology, 2017, 1(3): 143-163. doi: 10.3934/Allergy.2017.3.143 |
[3] | Shancy Petsel Jacob, Chikkamenahalli Lakshminarayana Lakshmikanth, Thomas M. McIntyre, Gopal Kedihitlu Marathe . Platelet-activating factor and oxidized phosphatidylcholines do not suppress endotoxin-induced pro-inflammatory signaling among human myeloid and endothelial cells. AIMS Allergy and Immunology, 2017, 1(3): 108-123. doi: 10.3934/Allergy.2017.3.108 |
[4] | Ryuta Muromoto, Kenji Oritani, Tadashi Matsuda . IL-17 signaling is regulated through intrinsic stability control of mRNA during inflammation. AIMS Allergy and Immunology, 2022, 6(3): 188-199. doi: 10.3934/Allergy.2022014 |
[5] | Ken S. Rosenthal . Immune monitoring of the body’s borders. AIMS Allergy and Immunology, 2018, 2(3): 148-164. doi: 10.3934/Allergy.2018.3.148 |
[6] | Zinia Pervin, Anika Tasnim, Hasib Ahamed, Md Al Hasibuzzaman . Epigenetic regulation of the COVID-19 pathogenesis: its impact on the host immune response and disease progression. AIMS Allergy and Immunology, 2023, 7(1): 60-81. doi: 10.3934/Allergy.2023005 |
[7] | Djo Hasan . Purinergic P2X7R expressed on regulatory T cells potentially links molecular mimicry to autoimmune responses. AIMS Allergy and Immunology, 2024, 8(2): 80-123. doi: 10.3934/Allergy.2024006 |
[8] | Katarzyna Nazimek . The complex functions of microRNA-150 in allergy, autoimmunity and immune tolerance. AIMS Allergy and Immunology, 2021, 5(4): 195-221. doi: 10.3934/Allergy.2021016 |
[9] | Rosa Molfetta, Beatrice Zitti, Angela Santoni, Rossella Paolini . Ubiquitin and ubiquitin-like modifiers modulate NK cell-mediated recognition and killing of damaged cells. AIMS Allergy and Immunology, 2017, 1(4): 164-180. doi: 10.3934/Allergy.2017.4.164 |
[10] | Stefano Regis, Fabio Caliendo, Alessandra Dondero, Francesca Bellora, Beatrice Casu, Cristina Bottino, Roberta Castriconi . Main NK cell receptors and their ligands: regulation by microRNAs. AIMS Allergy and Immunology, 2018, 2(2): 98-112. doi: 10.3934/Allergy.2018.2.98 |
Recent advances in genetic and environmental contributions to autoimmunity suggest that interaction between genetic elements and epigenetic changes caused by environmental agents may be responsible for inducing autoimmune diseases (ADs). Autoimmunity arises when immune responses mounted in the host are directed against self-components as a result of the loss of self-tolerance. ADs may be ether tissues-pecific where unique tissue-specific antigens are targeted, or systemic in which multiple tissues are affected and a variety of apparently ubiquitously expressed autoantigens are targeted [1,2] (Table 1). The affliction of autoimmunity is believed to develop when genetically predisposed individuals encounter environmental agents that trigger it. The environmental agents that are revered in this respect are stress and the viruses [3,4,5,6,7,8,9,10,11,12,13,14,15], which are operatives in this scene as stimuli for the activation of the nuclear factor (NF-KB), a transcription factor which specifically binds promoter DNA to activate target gene expression.
Organ specific autoimmune diseases | ||
Organ | Disease(s) | Self-Antigen |
Adrenal cells | Addison's disease | Cytochrome P-450 antigens |
Red blood cells | Autoimmune haemolitic anaemia | Red blood cell membrane proteins |
Platelets | Idiopathic thrombocytopaenic purpura | Platelet antigens |
Stomach | Pernicious anaemia | Gastric parietal cell antigens |
Small bowel | Coeliac sprue (gluten eneteropathy) | Transglutaminase |
Thyroid | Hashimoto's thyroiditis Grave's disease | Thyroid cell antigens Thyroid-stimulating hormone receptor |
Muscle | Myasthenia gravis | Acetylcholine receptors |
Pancreatic islets | Type 1 diabetes | Beta cell antigens |
Hepatocytes | Autoimmune hepatitis | Hepatocyte antigens (cytochrome P-450 2D6) |
Bile duct cells | Primary biliary cirrhosis | Intra-hepatic bile duct |
Heart | Rheumatic heart disease | Myocardial antigens |
Kidney/lung | Goodpasture's syndrome | Basement membrane antigens |
Systematic autoimmune diseases | ||
Disease(s) | Self-Antigen | |
Ankylosing sponkylitis | Vertebrae | |
Multiple sclerosis | Brain or white matter | |
Rheumatoid arthritis | Connective tissue, IgG | |
Systemic lupus erythematosus | DNA nuclear protein RBC and platelet membranes | |
Scleroderma | Nuclei, heart, lungs, gastrointestinal tract, kidney | |
Sjogren's syndrome | Salivary gland, liver, kidney, thyroid |
The transcription factor NF-ΚB is involved in the regulation of a large number of genes that control various aspects of the immune and inflammatory responses. According to Zhu et al. [16], NF-ΚB is a family of structurally related transcription factors. In mammals the NF-ΚB family consists of five members: NF-ΚB1 (p105/50), NF-ΚB2 (p100/52), RelA (p65), RelB, and c-Rel. They all have a structurally conserved N-terminal 300-amino-acid Rel homology domain (RHD), which contains sequences responsible for dimerization, nuclear translocation and DNA binding. Only RelA, RelB and c-Rel have a transactivation domain, which is non-homologous and located at the C-termini of the proteins. The other two NF-ΚB proteins, NF-ΚB1 and NF-ΚB2, lack a transactivation domain but instead contain seven ankyrin repeats, a 33-amino-acid characteristic motif of the inhibitor of NF-ΚB, (IΚB), that mediates protein-protein interactions. The five NF-ΚB proteins above can form 15 transcription factors through homo-or hetero-dimerization [17]: the main activated forms being RelA: p50 and RelB: p52. These NF-ΚB family members play critical roles in a wide variety of biological processes, including immune and inflammatory responses, development, cell growth and apoptosis. In unstimulated cells, the NF-ΚB dimers are sequestered in the cytoplasm by a family of inhibitors called IΚBs (IΚBα, IΚBβ, IΚBε and IΚBγ, IΚBδ, IΚBζ and Bcl-3), which are proteins that contain multiple copies of the sequence ankyrin repeats. By virtue of their ankyrin repeat domains, the IΚB proteins mask the nuclear localization signals of NF-ΚB proteins and keep them sequestered in an inactive state in the cytoplasm [18]. The NF-ΚB dimer becomes activated through degradation of the IΚB following phosphorylation of specific serines in the IΚB proteins by the IΚB-kinase complex (IKK), leading to their ubiquitination and thus allowing the liberation and nuclear translocation of NF-ΚB dimers to induce gene expression.
The NF-ΚB is recognized as a master transcription factor that responds to diverse stimuli by activating the expression of stress-response genes. Multiple signals, including cytokines, growth factors, engagement of the T cell receptor, bacterial and viral products, various forms of radiation and the oxidative stress, induce NF-ΚB transcriptional activity [19,20,21]. We are particularly interested in, and will limit ourselves to, the mechanism by which NF-ΚB is activated by oxidative stress and the viruses, the latter being represented by the gamma herpesviruses KSHV and EBV.
In respiring cells, a small amount of consumed oxygen is reduced in a specific way, yielding a variety of highly reactive chemical entities collectively called reactive oxygen species (ROS) or reactive oxidative intermediates (ROIs) and include hydrogen peroxide (H2O2), nitric oxide radical (NO), superoxide anion (O2–) and hydroxyl radical (OH–). A state of moderately increased levels of intracellular ROS is referred to as cellular oxidative stress [19,22]. Oxidative stress is caused by an imbalance between the production of oxidants and/or decreased ability to detoxify those oxidants. ROS activate NF-ΚB by various mechanisms [23,24]. Studies have been made which suggest that IΚBα phosphorylation and degradation might be the step that is responsive to oxidative stress. NF-ΚB activation has been suggested to be regulated by the levels of oxidants inside cells [22]. Thus it is observed that H2O2, a ROS, regulates NF-ΚB activation through alternative phosphorylation of IΚBα. While typically IΚBα is usually phosphorylated on serines 32 and 36, which leads to its ubiquitination and degradation, ROS H2O2 affects the phosphorylation of IΚBα on tyrosine Tyr42 or other tyrosine residues, and IΚBα may or may not be degraded as part of the process [25,26,27,28,29]. IKK is not required in this case, and IΚBα phosphorylation may be mediated by kasein Kinase II as well as a tyrosine kinase. Degradation of IΚBα may not be necessary in this case because Tyr42-phosphorylated IΚBα is bound by the SH2 domains of p85α regulatory subunit of PI3K, thus unmasking NF-ΚB and allowing it to translocate to the nucleus [30,31,32]. PI3K as well as c-Src have been implicated in alternative phosphorylation of IΚBα.
NF-ΚB activation is imperative for latent infection of gamma herpesviruses. KSHV infection activates IKKβ and IKKε to enable host NF-ΚB activation and KSHV latent infection. Biochemical and genetic experiments identified RelA as a key player downstream of IKKβ and IKKε, i.e., IKKβ and IKKε were essential for phosphorylation of serines S536 and S468 of RelA, respectively [33]. That the expression of the phosphorylation-resistant RelAS536A increased KSHV lytic genes expression and impaired latent infection is further seen as completing evidence. NF-ΚB activation is coordinated by IKKβ and IKKε, which sequentially phosphorylate RelA in a site-specific manner to enable latent infection after KSHV de novo infection. As a further evidential support, knockdown of IKKβ and IKKε impairs NF-ΚB activation and elevates KSHV lytic genes expression resulting in abrogation of the latent infection. Please recall here that RelA is one of the five members of NF-ΚB family that is the most abundantly and ubiquitously expressed and is the transcriptionally active subunit of the predominant RelA: p50 dimer. Post translational modifications of the RelA subunit, e.g., phosphorylation and acetylation, are important means to regulate NF-ΚB-dependent gene expression [34,35,36,37]. Activation of NF-ΚB through viral infection results in the transactivation of the NF-ΚB sitec-ontaining viral promoter, resulting in installment of latency [38].
In latent infection, the full viral genome is retained in the host, but its expression is dramatically restricted, such that few viral antigens and no viral particles are produced. To qualify as latency, this cryptic form of infection must display two additional properties: persistence and reversibility, i.e., the capacity of the genome, under the appropriate circumstances (e.g., oxidative stress) to be fully reactivated with the production of infectious progeny, (the lytic replication), is the key requirement of latency. It is the property of reversibility that allows latent infections to avoid abortive infection, or a dead end, and instead become an effective mechanism of viral persistence. Efficient establishment of latency allows the viral genome to persist despite the host immune responses to many viral antigens, and in the face of other potentially adverse signals in the microenvironment. When environmental conditions warrant, appropriate signals can trigger the full repertoire of viral gene expression, allowing viral production and spread to resume.
The herpesviruses, alpha, beta and gamma subfamilies are the viruses capable of true latency as described above. In fact all herpesviruses share a propensity to establish latent infection [39,40]. The herpesviruses HBV and KSHV encode multiple viral miRNAs which mimic cellular miRNAs and modulate cellular and viral gene expression [41,42,43,44]. Some of the viral miRNAs have been implicated in maintaining latent infection and altering the balance between latent/lytic infection [45,46]. The first study showing that miRNAs can be encoded in the viral genome was published in 2004 [47]. The unique ability of the herpesviruses to establish long term latent infections means that these viruses need to block protective host innate or adaptive immune responses over the long term while minimizing the expression of potentially antigenic viral proteins, and this is accomplished by the viral miRNAs. Employing quantitative algorithms prediction, the authors, Grey et al. and Lu et al. [48,49] determined that the herpesviruses employ viral miRNAs to suppress expression of their own genes, including their immediate early genes. These authors concluded that these viruses use viral miRNAs-mediated suppression of immediate early genes as part of their strategy to enter and maintain latency. The lytic cascade is reinitiated with the expression of the immediate early genes (RTA, BZLF1 and BRLF1). Multiple viral miRNAs are transcribed during latency. The KSHV encoded miRNAs (miR-K12-9-5p and miR-12-7-5p) have been shown to directly regulate and inhibit the transcription of the master lytic switch protein, the viral immediate early gene known as the replication and transcription activator (RTA), and in this way they contribute to the maintenance of viral latency. They target the expression of RTA at the translational level [50,51,52]. Fang Lu et al. observed that EBV-coded miR-155 attenuates NF-ΚB signaling and stabilizes latent virus persistence [41]. miRNA-155 is important for the stable maintenance of EBV genomes during latent infection. Several latency genes have been observed to influence the activation of NF-ΚB which turns out to be important in the maintenance of latency. EBV encoded latency membrane protein 1 (LMP1) is a potent activator of NF-ΚB signaling pathways and is essential for EBV immortalization of B lymphocytes. Finally, the observations by Lei et al. [53] established that the viral activation of NF-ΚB is essential for the establishment of latency.
EBV lytic genes are expressed in a temporally regulated cascade. Following the activation, transcription and expression of the lytic master switch RTA, the switch from the latent to the replicative form of EBV infection is mediated by the two immediate early proteins BZLF1 and BRLF1, which are transcription factors that together activate the entire lytic viral cascade of gene expression, ultimately resulting in the production of infectious viral particles [54]. In natural viral life cycle, the differentiation of the cells triggers the abrogation of latency and entrance into the lytic phase of infection. In the situations leading to virus-induced autoimmunity, however, it is cellular stress, in particular for our purpose, oxidative stress that triggers latency termination [5].
The switch between latency and lytic replication is regulated by epigenetic factors: (ⅰ) hypomethylation of the promoter of replication and transcription activator, RTA (which, as said above, is essential for the lytic switch) leads to viral reactivation; (ⅱ) histone acetylation induces viral replication by influencing protein-protein associations and transcription factor binding [55]; and (ⅲ) it is the general and established situation that post-transcriptional gene regulation of mRNA turnover and translation is mediated by microRNAs and RNA-binding proteins in events identified as network motifs [56,57,58,59,60]. The network motifs in the images of feedback and feed-forward mechanisms or loops [61] are defined as small gene regulating circuits that occur more often than can be expected by chance. Feed-back motifs are prominent throughout biology: they can be identified when protein-protein interactions are combined with transcriptional interactions [62] or when transcriptional interactions and miRNA-mediated post-transcriptional interactions are involved. We hypothesize that this latter scenario and mode of feedback motif occurs with stress-activated NF-ΚB (a transcription factor) and viral miRNAs: the ensemble being depicted as NF-ΚB <--> miRNA, signifying a reciprocal regulation between the viral miRNA and NF-ΚB in which NF-ΚB regulates viral miRNA and is itself regulated by the same miRNA. NF-ΚB gets directly involved in up-regulation and down-regulation of miRNAs [63]. We suggest that the relationship above induces a down-regulation of the viral miRNA with the consequence that the viral miRNA gets sequestered (titrated out) and neutralized by the RTA site with which it interacts through a process termed "sponging". Equally interacting with the RTA site is the stress-activated NF-ΚB. But the down-regulation of the viral miRNA by NF-ΚB in the feed-back circuit (formula) above accentuates the viral miRNA sponging, making it (the viral miRNA) no longer in excess but reduced to below some minimal proportionate value. This frees the RTA site for the transcription factor NF-ΚB interaction and it results in the activation and transcription of RTA: we say this event spells switching on of the master lytic switch, if you will!
In the situation of feed-forward circuitry, a regulator X regulates the expression of a target Z via a direct or indirect path through a regulator Y, the whole setting represented as X/Z/Y, which in our particular case is translated as "stress-activated NF-ΚB/RTA/viral miRNA". This feed-forward loop reveals a mechanism through which stress-activated NF-ΚB simultaneously activates RTA transcription and limits its translation through activation of the viral miRNA.
In summary, NF-ΚB is unusually activated: its viral activation via serine residues phosphorylation by IKKβ and IKKε leads to viral latency, while activation by oxidative stress (ROS) occurs via tyrosine phosphorylation of IΚBα which then complexes with NF-ΚB and leads to abrogation of the viral latency. To facilitate understanding of the above we abbreviate that "viral activation of NF-ΚB leads to viral latency; while stress activation of the same molecular entity, the NF-ΚB, leads instead to abrogation of the latency". Thus NF-ΚB emerges as the converging focus between stress and the viruses in their efforts as separate environmental agents that trigger autoimmunity. The phosphorylation of particular amino acid residues of a protein molecule modulates that protein's polymorphic conformations, appropriately. For a transcription factor, TF, a given conformation influences its choice of cognate DNA sequence recognition as well as its interaction with a neighboring TF or other proteins and molecules. The transcription factor, NF-ΚB, in particular is reputed to be involved in a battery of regulatory functions [23,64]. We interpret this to mean that as a TF that is variously and differentially phosphorylated, NF-ΚB is capable of assuming or exhibiting a multitude of polymorphic conformations that we choose to call them "derivative isoforms". Thus the virus activation of NF-ΚB that occurs via its phosphorylation by IKKβ and IKKε at serines S536 and S468 generates the derivative isoforms with the potential to activate the transcription of viral latency genes thereby installing and maintaining a latent infection. On the other hand oxidative stress-activation of NF-ΚB occurs via complexation with IΚBα that is phosphorylated at tyrosine Tyr42 and yields derivative isoforms with the attributes that activate the transcription of RTA, the master lytic switch, thereby precipitating abrogation of the viral latency and engendering the lytic cycle phase. The above two alternative involvements of NF-ΚB portray its versatility and sophistication and confirms the difference in mechanism between viral-and stress-activations of NF-ΚB. The revelation of the feedback and feedforward network motifs cited above represents evidence of regulatory circuits involving stress-activated NF-ΚB and viral miRNAs: the feedback mechanism co-accomplishes with the feed-forward loop, in a relation possibly reverberative of a cooperativity, the expression and switching on of RTA, the master lytic switch. This expressed RTA in turn activates the transcription of the immediate early genes BZLF1 and BRLF1: the two transcription factors that mobilize the expression of the whole set of lytic genes, resulting in the procreation of the lytic cascade. Interpret this simply as the activation of NF-ΚB by stress materializes in a dual prong: feedback and feedforward loops that cooperate in the switching on of RTA and thus abrogate the viral latency, consequentially setting in trend or motion the journey of the virus to the triggering of autoimmunity (Figure 1) [65].
(1) In man, autoimmunity is an event in which the immune responses mounted in the host are directed against self-components as a result of the loss of self-tolerance. The resulting autoimmune diseases are either tissue-specific when a particular tissue is affected, or systemic when a number of tissues are enrolled.
(2) To happen, autoimmunity requires triggering by environmental factors: the viruses and oxidative stress, in genetically primed individuals. The viruses and stress feature as stimuli for the activation of the transcription factor NF-ΚB.
(3) Post-transcriptional gene regulation of mRNA turnover and translation is mediated by microRNAs and RNA-binding proteins in events identified as network motifs, in the images of feedback and feed-forward mechanisms. The feedback network motif in which transcriptional interactions and miRNA-mediated post-transcriptional interactions are involved occurs with stress-activated NF-ΚB and viral miRNAs in a reciprocal regulation between NF-ΚB and viral miRNAs such that NF-ΚB regulates the viral miRNAs and is itself regulated by the same miRNAs.
(4) NF-ΚB and viral miRNAs compete for RTA site with which they interact. The NF-ΚB regulation of miRNA above is a down-regulation that consequents in miRNA depletion by RTA site in a process called sponging, thus sparing the RTA site for NF-ΚB; this scenario favors NF-ΚB-activated transcription and expression of RTA, the lytic master switch, leading to abrogation of the viral latency and to a lytic replication.
(5) The feed-forward network motif reveals a mechanism through which stress-activated NF-ΚB simultaneously activates RTA transcription and limits its translation through activation of the viral miRNA.
(6) Finally, as Figure 1 displays, the feedback and feed-forward mechanisms cooperate in the switching on of RTA which in turn activates the transcription and expression of the immediate early genes BZLF1 and BRLF1. These two immediate early genes mobilize the expression of lytic genes and thus abrogate the viral latency, consequentially setting in trend the journey of the virus to the triggering of autoimmunity.
This investigation was supported by grants from the NSW Health Department. The author would like to thank Professor Schlink for providing the facilities for the investigation. Dr Temajo is particularly grateful to his wife Julianne Temajo for her enlightening suggestions in their learned and civilized discourse.
All authors declare no conflicts of interest in this review.
[1] | Petersen R (2012) Reactive secondary sequence oxidative pathology polymer model and antioxidant tests, Int Res J Pure Appl Chem 2: 247–285. |
[2] |
Singer S, Nicolson G (1972) The fluid mosaic model of the structure of cell membranes. Science 175: 720–731. doi: 10.1126/science.175.4023.720
![]() |
[3] |
Nicolson G (2014) The fluid-mosaic model of membrane structure: still relevant to understanding the structure, function and dynamics of biological membranes after more than 40 years. Biochim Biophys Acta 1838: 1451–1466. doi: 10.1016/j.bbamem.2013.10.019
![]() |
[4] | Michael J, Sircar S, (2011) The Cell Membrane, In: Fundamentals of Medical Physiology, New York: Thieme Medical Publishers, 9–16. |
[5] |
Jeong M, Kang J (2008) Acrolein, the toxic endogenous aldehyde, induces neurofilament-L aggregation. BMB Rep 41: 635–639. doi: 10.5483/BMBRep.2008.41.9.635
![]() |
[6] |
Torosantucci R, Mozziconacci O, Sharov V, et al. (2012) Chemical modifications in aggregates of recombinant human insulin induced by metal-catalyzed oxidation: covalent crosslinking via Michael addition to tyrosine oxidation products. Pharm Res 29: 2276–2293. doi: 10.1007/s11095-012-0755-z
![]() |
[7] |
Rubenstein M, Leibler L, Bastide J (1992) Giant fluctuations of crosslink positions in gels. Phys Rev Lett 68: 405–407. doi: 10.1103/PhysRevLett.68.405
![]() |
[8] |
Nossal R (1996) Mechanical properties of biological gels. Physica A 231: 265–276. doi: 10.1016/0378-4371(95)00455-6
![]() |
[9] | Barsky S, Plischke M, Joos B, et al. (1996) Elastic properties of randomly cross-linked polymers Phys Rev E 54: 5370–5376. |
[10] | Ulrich S, Zippelius A, Benetatos P (2010) Random networks of cross-linked directed polymers. Phys Rev E 81: 021802. |
[11] | Rodriquez F, (1996) 11.3 Polymer degradation, In: Principles of Polymer Systems, 4 Eds., Washington D.C.: Taylor and Francis, 398–399. |
[12] | Dröge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82: 47–95. |
[13] |
Valko M, Leibfritz D, Moncol J, et al. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44–84. doi: 10.1016/j.biocel.2006.07.001
![]() |
[14] |
Floyd R, Towner R, He T, et al. (2011) Translational research involving oxidative stress diseases of aging. Free Radic Biol Med 51: 931–941. doi: 10.1016/j.freeradbiomed.2011.04.014
![]() |
[15] | Sena L, Chandel N ( 2012) Physiological roles of mitochondrial reactive oxygen species. Mol Cell 48: 158–167. |
[16] |
Labunskyy V, Gladyschev V (2013) Role of reactive oxygen species-mediated signaling in aging. Antioxid Redox Signal 19: 1362–1372. doi: 10.1089/ars.2012.4891
![]() |
[17] |
Hill S, Remmen H (2014) Mitochondrial stress signaling in longevity: a new role for mitochondrial function in aging. Redox Biol 2: 936–944. doi: 10.1016/j.redox.2014.07.005
![]() |
[18] |
Schieber M, Chandel N (2014) ROS function in redox signaling and oxidative stress. Curr Biol 24: R453–R462. doi: 10.1016/j.cub.2014.03.034
![]() |
[19] | Girotti A (1998) Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 39: 1529–1542. |
[20] | Beckman K, Ames B (1998) The free radical theory of aging matures. Physiol Rev 78: 547–581. |
[21] |
Valko M, Rhodes C, Moncol, et al. (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interac 160: 1–40. doi: 10.1016/j.cbi.2005.12.009
![]() |
[22] | Silva J, Coutinho O (2010) Free radicals in the regulation of damage and cell death-basic mechanisms and prevention. Drug Discov Ther 4: 144–167. |
[23] |
Jacob K, Hooten N, Trzeciak A, et al. (2013) Markers of oxidant stress that are clinically relevant in aging and age-related disease. Mech Ageing Dev 134: 139–157. doi: 10.1016/j.mad.2013.02.008
![]() |
[24] | Phaniendra A, Jestadi D, Periyasamy L (2015) Free radicals: properties, sources, targets, and their implication in various diseases. Ind J Clin Biochem 30: 11–26. |
[25] |
Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol Soc 11: 298–300. doi: 10.1093/geronj/11.3.298
![]() |
[26] |
Shigenaga M, Hagen T, Ames B (1994) Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 91: 10771–10778. doi: 10.1073/pnas.91.23.10771
![]() |
[27] | Balaban R, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging. Cell 120: 483–495. |
[28] |
Harman D (2006) Free radical theory of aging: an update. Ann NY Acad Sci 1067: 10–21. doi: 10.1196/annals.1354.003
![]() |
[29] |
Colavitti R, Finkel T (2005) Reactive oxygen species as mediators of cellular senescence. IUBMB Life 57: 277–281. doi: 10.1080/15216540500091890
![]() |
[30] |
Ziegler D, Wiley C, Velarde M (2015) Mitochondrial effectors of cellular senescence: beyond the free radical theory of aging. Aging Cell 14: 1–7. doi: 10.1111/acel.12287
![]() |
[31] |
Eichenberger K, Böhni P, Wintehalter K, et al. (1982) Microsomal lipid peroxidation causes an increase in the order of the membrane lipid domain. FEBS Letters 142: 59–62. doi: 10.1016/0014-5793(82)80219-6
![]() |
[32] |
Kaplán P, Doval M, Majerová Z, et al. (2000) Iron-induced lipid peroxidation and protein modification in endoplasmic reticulum membranes. Protection by stobadine. Int J Biochem Cell Biol 32: 539–547. doi: 10.1016/S1357-2725(99)00147-8
![]() |
[33] |
Solans R, Motta C, Solá R, et al. (2000) Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis. Arthritis Rheum 43: 894–900. doi: 10.1002/1529-0131(200004)43:4<894::AID-ANR22>3.0.CO;2-4
![]() |
[34] |
Pretorius E, Plooy J, Soma P, et al. (2013) Smoking and fluidity of erythrocyte membranes: a high resolution scanning electron and atomic force microscopy investigation. Nitric Oxide 35: 42–46. doi: 10.1016/j.niox.2013.08.003
![]() |
[35] |
de la Haba C, Palacio J, Martínez P, et al. (2013) Effect of oxidative stress on plasma membrane fluidity of THP-1 induced macrophages. Biochim Biophys Acta 1828: 357–364. doi: 10.1016/j.bbamem.2012.08.013
![]() |
[36] | Alberts B, Johnson A, Lewis J, et al. (2002) The Lipid Bilayer, In: Molecular Biology of the Cell, 4 Eds., New York: Garland Science. |
[37] |
Weijers R (2012) Lipid composition of cell membranes and its relevance in type 2 diabetes mellitus. Curr Diabetes Rev 8: 390–400. doi: 10.2174/157339912802083531
![]() |
[38] |
Benderitter M, Vincent-Genod L, Pouget J, et al. (2003) The cell membrane as a biosensor of oxidative stress induced by radiation exposure: a multiparameter investigation. Radiat Res 159: 471–483. doi: 10.1667/0033-7587(2003)159[0471:TCMAAB]2.0.CO;2
![]() |
[39] |
Zimniak P (2011) Relationship of electrophilic stress to aging. Free Radic Biol Med 51: 1087–1105. doi: 10.1016/j.freeradbiomed.2011.05.039
![]() |
[40] |
Wang S., Von Meerwall E, Wang SQ, et al. (2004). Diffusion and rheology of binary polymer mixtures. Macromolecules 37: 1641–1651. doi: 10.1021/ma034835g
![]() |
[41] | Williams R (1989) NMR studies of mobility within protein structure. Euro J Biochem 183: 479–497. |
[42] | Sapienza, P, Lee A (2010) Using NMR to study fast dynamics in proteins: methods and applications. Curr Opin Pharmacol 10: 723–730. |
[43] | Petersen R (2014) Computational conformational antimicrobial analysis developing mechanomolecular theory for polymer biomaterials in materials science and engineering. Int J Comput Mater Sci Eng 3: 145003. |
[44] | Goldstein D, (1990) Chapter 143 Serum Calcium, In: Walker H, Hall W, Hurst J, Editors, Clinical Methods: The History, Physical, and Laboratory Examinations, 3 Eds., Boston: Butterworths. |
[45] | Tung IC (1991) Application of factorial design to SMC viscosity build-up. Polym Bull 25: 603–610. |
[46] | Peters S, (1998) Particulate Fillers, In: Handbook of Composites, 2 Eds., New York: Chapman & Hall, 242–243. |
[47] |
Gaucheron F (2005) The minerals of milk. Reprod Nutr Dev 45: 473–483. doi: 10.1051/rnd:2005030
![]() |
[48] | Komabayashi T, Zhu Q, Eberhart R, et al. (2016) Current status of direct pulp-capping materials for permanent teeth. Dent Mater J 35: 1–12. |
[49] | Petersen R, Vaidya U, (2011) Chapter 16 Free Radical Reactive Secondary Sequence Lipid Chain-Lengthening Pathologies, In: Micromechanics/Electron Interactions for Advanced Biomedical Research, Saarbrücken: LAP LAMBERT Academic Publishing Gmbh & Co. KG., 233–287. |
[50] | McMurry J, (2004) Organic Chemistry 6 Eds, Belmont, CA: Thompson Brooks/Cole., 136–138. |
[51] |
Esterbauer H, Schaur R, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81–128. doi: 10.1016/0891-5849(91)90192-6
![]() |
[52] |
Lovell M, Xie C, Markesbery W (2000) Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic Biol Med 29: 714–720. doi: 10.1016/S0891-5849(00)00346-4
![]() |
[53] |
Shi R, Rickett T, Sun W (2011) Acrolein-mediated injury in nervous system trauma and diseases. Mol Nutr Food Res 55: 1320–1331. doi: 10.1002/mnfr.201100217
![]() |
[54] |
Uchida K (1999) Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 9: 109–113. doi: 10.1016/S1050-1738(99)00016-X
![]() |
[55] |
Minko I, Kozekov I, Harris T, et al. (2009) Chemistry and biology of DNA containing 1,N2-deoxyguanosine adducts of the α,β-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem Res Toxicol 22: 759–778. doi: 10.1021/tx9000489
![]() |
[56] | Singh M, Kapoor A, Bhatnagar A (2014) Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls. Chem Biol Interact 234: 261–273. |
[57] |
Ishii T, Yamada T, Mori T, et al. (2007) Characterization of acrolein-induced protein cross-links. Free Radic Res 41: 1253–1260. doi: 10.1080/10715760701678652
![]() |
[58] | Michael J, Sircar S, (2011) Electrophysiology of Ion Channels, In: Fundamentals of Medical Physiology, New York: Thieme Medical Publishers, 43–46. |
[59] | Han P, Trinidad B, Shi J (2015) Hypocalcemia-induced seizure: demystifying the calcium paradox. ASN Neuro 7: 1–9. |
[60] |
Parekh A, Putney J (2005) Store-operated calcium channels. Physiol Rev 85: 757–810. doi: 10.1152/physrev.00057.2003
![]() |
[61] | Sherwood L, (2004) Endocrine Control of Calcium Metabolism, In: Human Physiology, 5 Eds., Belmont, CA: Thomson-Brooks/Cole, 733–742. |
[62] | Michael J, Sircar S, (2011) Mechanisms to Regulate Whole Body pH, In: Fundamentals of Medical Physiology, New York: Thieme Medical Publishers, 399–400. |
[63] | Lide D, (1996) Electrical Resistivity of Pure Metals, In: Handbook of Chemistry and Physics, 77 Eds., New York: CRC Press, 12-40–12-41. |
[64] |
Jendrasiak G, Smith R (2004) The interaction of water with the phospholipid head group and its relationship to the lipid electrical conductivity. Chem Phys Lipids 131: 183–195. doi: 10.1016/j.chemphyslip.2004.05.003
![]() |
[65] | Petersen R (2011) Bisphenyl-polymer/carbon-fiber-reinforced composite compared to titanium alloy bone implant. Int J Polym Sci 2011: 2341–2348. |
[66] | Callister W, (1997) Room Temperature Electrical Resistivity Values for Various Engineering Materials Table C.9, In: Materials Science and Engineering, New York: John Wiley & Sons, 796–798. |
[67] | Park B, Lakes R, (1992) Characterization of Materials II Table 4.1, In: Biomaterials, 2 Eds., New York: Plenum Press, 64. |
[68] | Halliday D, Resnick R, Walker J, (1993) 46-2 Electrical Conductivity, In: Fundamentals of Physics, 4 Eds., New York: JohnWiley & Son, 1210. |
[69] | Periodic Table of the Elements (2016) Sulfur-Electrical Properties accessed November 10, 2016. Available from: http://www.periodictable.com/Elements/016/data.html. |
[70] | Clandinin M, Cheema S, Field C, et al. (1991) Dietary fat: exogenous determination of membrane structure and cell function. FASEB J 5: 2761–2769. |
[71] | McMurry J, (2004) Biomolecules: Lipids, In: Organic Chemistry, 6 Eds., Belmont, CA: Thompson Brooks/Cole, 1027–1033. |
[72] | Sherwood L, (2004) Lipids, In: Human Physiology, 5 Eds., Belmont, CA: Thomson-Brooks/Cole, A12–A13. |
[73] | Villaláın J, Mateo C, Aranda F, et al. (2001) Membranotropic effects of the antibacterial agent triclosan. Arch Biochem Biophys 390: 128–136. |
[74] | Guillén J, Bernabeu A, Shapiro S, et al. (2004) Location and orientation of Triclosan in phospholipid model membranes. Eur Biophys J 33: 448–453. |
[75] | Alberts B, Johnson A, Lewis J, et al. (2002) Electron-Transport Chains and Their Proton Pumps, In: Molecular Biology of the Cell, 4 Eds., New York: Garland Science. |
[76] | Sherwood L, (2004) Acid-Base Balance, In: Human Physiology, 5 Eds., Belmont, CA: Thomson-Brooks/Cole, 571–577. |
[77] | Hüttemann M, Lee I, Grossman L, et al. (2012) Chapter X. phosphoylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respieration, apoptosis, and human disease. Adv Exp Med Biol 748: 237–264. |
[78] |
Srinivasan S, Avadhani N (2012) Cytochrome c oxidase dysfunction in oxidative stress. Free Radic Biol Med 53: 1252–1263. doi: 10.1016/j.freeradbiomed.2012.07.021
![]() |
[79] |
Finkel T, Holbrook N (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408: 239–247. doi: 10.1038/35041687
![]() |
[80] |
Brand M, Affourtit C, Esteves T, et al. (2004) Serial review: the powerhouse takes control of the cell: the role of mitochondria in signal transduction. Free Radic Biol Med 37: 755–767. doi: 10.1016/j.freeradbiomed.2004.05.034
![]() |
[81] | Tosato M, Zamboni V, Ferrini A, et al (2007) The aging process and potential interventions to extend life expectancy. Clinical Interv Aging 2: 401–412. |
[82] |
Murphy M (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1–13. doi: 10.1042/BJ20081386
![]() |
[83] |
Kagan V, Wipf P, Stoyanovsky D, et al. (2009) Mitochondrial targeting of electron scavenging antioxidants: regulation of selective oxidation vs random chain reactions. Adv Drug Deliv Rev 61: 1375–1385. doi: 10.1016/j.addr.2009.06.008
![]() |
[84] |
Niizuma K, Yoshioka H, Chen H, et al. (2010) Mitochondrial and apoptotoc neuronal death signaling pathways in cerebral ischemia. Biochim Biophys Acta 1802: 92–99. doi: 10.1016/j.bbadis.2009.09.002
![]() |
[85] | Michael J, Sircar S, (2011) Metabolic Pathways, In: Fundamentals of Medical Physiology, New York: Thieme Medical Publishers, 467–468. |
[86] | Halliwell B (1987) Oxidants and human disease: some new concepts. FASEB J 1: 358–364. |
[87] | Petersen R (2013) Free-radical polymer science structural cancer model: a review. Scientifica 2013: 143589. |
[88] | Alberts B, Johnson A, Lewis J, et al. (2002) Proteins Function, In: Molecular Biology of the Cell, 4 Eds., New York: Garland Science. |
[89] |
Reineri S, Bertoni A, Sanna E, et al. (2007) Membrane lipid rafts coordinate estrogen-dependent signaling in human platelets. Biochim Biophys Acta 1773: 273–278. doi: 10.1016/j.bbamcr.2006.12.001
![]() |
[90] |
Pamplona R, Portero-Otin M, Requena J, et al. (1999) A low degree of fatty acid unsaturation leads to lower lipid peroxidation and lipoxidation-derived protein modification in heart mitochondria of the longevous pigeon than in the short-lived rat. Mech Ageing Dev 106: 283–286. doi: 10.1016/S0047-6374(98)00121-3
![]() |
[91] |
Wang Y, Cui P (2015) Reactive carbonyl species derived from omega-3 and omega-6 fatty acids. J Agric Food Chem 63: 6293–6296. doi: 10.1021/acs.jafc.5b02376
![]() |
[92] | National Cancer Institute/National Institutes of Health/Department of Health and Human Services (2006) What You Need To Know About Cancer Bethesda, MD: NIH. |
[93] | Weinhouse S, Warburg O, Burk D, et al. (1956) On respiratory impairment in cancer cells. Science 124: 269–270. |
[94] | Gillies R, (2001) The Tumour Microenvironment: Causes and Consequences of Hypoxia and Acidity, Novartis Foundation Symposium 240, New York: JohnWiley & Sons. |
[95] | Stavridis J, (2008) Oxidation: the Cornerstone of Carcinogenesis, New York: Springer. |
[96] |
Grek C, Tew K (2010) Redox metabolism and malignancy. Current Opin Pharmacol 10: 362–368. doi: 10.1016/j.coph.2010.05.003
![]() |
[97] |
Fogg V, Lanning N, MacKeigan J (2011) Mitochondria in cancer: at the crossroads of life and death. Chin J Cancer 30: 526–539. doi: 10.5732/cjc.011.10018
![]() |
[98] |
Hielscher A, Gerecht S (2015) Hypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships. Free Radic Biol Med 79: 281–291. doi: 10.1016/j.freeradbiomed.2014.09.015
![]() |
[99] |
Görlach A, Dimova E, Petry A, et al. (2015) Reactive oxygen species, nutrition, hypoxia and diseases: problems solved? Redox Biol 6: 372–385. doi: 10.1016/j.redox.2015.08.016
![]() |
[100] | Tafani M, Sansone L, Limana F, et al. (2016) The interplay of reactive oxygen species, hypoxia, inflammation, and sirtuins in caner initiation and progression. Oxid Med Cell Longev 2016: 1–18. |
[101] | Peacock J, Calhoun A, (2006) Polymer Chemistry Properties and Applications, Munich, Germany: Hanser. |
[102] |
Mironi-Harpaz I, Narkis M, Siegmann A (2007) Peroxide crosslinking of a styrene-free unsaturated polyester. J Appl Polym Sci 105: 885–892. doi: 10.1002/app.25385
![]() |
[103] |
Wang Y, Woodworth L, Han B (2011) Simultaneous measurement of effective chemical shrinkage and modulus evolutions during polymerization. Exp Mech 51: 1155–1169. doi: 10.1007/s11340-010-9410-y
![]() |
[104] |
Jansen K, Vreugd de J, Ernst L (2012) Analytical estimate for curing-induced stress and warpage in coating layers. J Appl Polym Sci 126: 1623–1630. doi: 10.1002/app.36776
![]() |
[105] | Weinberg R, (2007) 14.3 The epithelial-mesenchymal transition and associated loss of E-cadherin expression enable carcinoma cells to become invasive, In: The Biology of Cancer, New York: Garland Science, 597–624. |
[106] |
Wenger J, Chun S, Dang D, et al. (2011) Combination therapy targeting cancer metabolism. Med Hypotheses 76: 169–172. doi: 10.1016/j.mehy.2010.09.008
![]() |
[107] |
Vinogradova T, Miller P, Kaverina I (2009) Microtubule network asymmetry in motile cells: role of Golgi-derived array. Cell Cycle 8: 2168–2174. doi: 10.4161/cc.8.14.9074
![]() |
[108] |
Lindberg U, Karlsson R, Lassing I, et al. (2008) The microfilament system and malignancy. Semin Cancer Biol 18: 2–11. doi: 10.1016/j.semcancer.2007.10.002
![]() |
[109] |
San Martín A, Griendling K (2010) Redox control of vascular smooth muscle migration. Antioxid Redox Signal 12: 625–640. doi: 10.1089/ars.2009.2852
![]() |
[110] | Copstead LE, Banasik J, (2005) Pathophysiology, 6 Eds., St. Louis, MO: Elsevier Saunders, 221. |
[111] |
Li Z, Hannigan M, Mo Z, et al. (2003) Directional Sensing Requires Gβγ-Mediated PAK1 and PIXα-Dependent Activation of Cdc42. Cell 114: 215–227. doi: 10.1016/S0092-8674(03)00559-2
![]() |
[112] |
Hattori H, Subramanian K, Sakai J, et al. (2010) Small-molecule screen identifies reactive oxygen species as key regulators of neutrophile chemotaxis. PNAS 107: 3546–3551. doi: 10.1073/pnas.0914351107
![]() |
[113] |
Parisi F, Vidal M (2011) Epithelial delamination and migration: lessons from Drosophila. Cell Adh Migr 5: 366–372. doi: 10.4161/cam.5.4.17524
![]() |
[114] |
Barth A, Caro-Gonzalez H, et al. (2008) Role of adenomatous polyposis coli (APC) and microtubules in directional cell migration and neuronal polarization. Semin Cell Dev Biol 19: 245–251. doi: 10.1016/j.semcdb.2008.02.003
![]() |
[115] | Dent E, Gupton S, et al. (2010) The growth cone cytoskeleton in axon outgrowth and guidance. Cold Spring Harb Perspect Biol 3: a001800. |
[116] |
Saraswathy S, Wu G, et al. (2006) Retinal microglial activation and chemotaxis by docosahexaenoic acid hydroperoxide. Invest Ophthalmol Vis Sci 47: 3656–3663. doi: 10.1167/iovs.06-0221
![]() |
[117] |
Dunlop R, Dean R, Rodgers K (2008) The impact of specific oxidized amino acids on protein turnover in J774 cells. Biochem J 410: 131–140. doi: 10.1042/BJ20070161
![]() |
[118] |
Darling E, Zauscher S, Block J (2007) A thin-layer model for viscoelastic, stress-relaxation testing of cells using atomic force microscopy: do cell properties reflect metastatic potential. Biophys J 92: 1784–1791. doi: 10.1529/biophysj.106.083097
![]() |
[119] |
Fleischer F, Ananthakrishnan R, (2007) Actin network architecture and elasticity in lamellipodia of melanoma cells. New J Phys 9: 420. doi: 10.1088/1367-2630/9/11/420
![]() |
[120] | Pokorný J, Jandový A, Nedbalová (2012) Mitochondrial metabolism-neglected link of cancer transformation and treatment. Prague Med Rep 113: 81–94. |
[121] |
Qian Y, Luo J, Leonard S, et al. (2003) Hydrogen peroxide formation and actin filament reorganization by Cdc42 are essential for ethanol-induced in vitro angiogenesis. J Biol Chem 278: 16189–16197. doi: 10.1074/jbc.M207517200
![]() |
[122] |
Gawdzik B, Księzopolski J, Matynia T (2003) Synthesis of new free-radical initiators for polymerization. J Appl Polym Sci 87: 2238–2243. doi: 10.1002/app.11585
![]() |
[123] |
Miller Y, Worrall D, Funk C, et al. (2003) Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase. Mol Biol Cell 14: 4196–4206. doi: 10.1091/mbc.E03-02-0063
![]() |
[124] |
Ushio-Fukai M, Nakamura Y (2008) Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266: 37–52. doi: 10.1016/j.canlet.2008.02.044
![]() |
[125] |
Taparowsky E, Suard Y, Fasano O (1982) Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 300: 762–765. doi: 10.1038/300762a0
![]() |
[126] |
Swaminathan V, Mythreye K, Tim O'Brien E, et al. (2011) Mechanical Stiffness grades metastatic potential in patient tumor cells and in cancer cell lines. Cancer Res 71: 5075–5080. doi: 10.1158/0008-5472.CAN-11-0247
![]() |
[127] |
Xu W, Mezencev R, Kim B, et al. (2012) Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells. PLoS ONE 7: e46609. doi: 10.1371/journal.pone.0046609
![]() |
[128] |
Hoyt K, Castaneda B, Zhang M, et al. (2008) Tissue elasticity properties as biomarkers for prostate cancer. Cancer Biomark 4: 213–225. doi: 10.3233/CBM-2008-44-505
![]() |
[129] |
Ghosh S, Kang T, Wang H, et al. (2011) Mechanical phenotype is important for stromal aromatase expression. Steroids 76: 797–801. doi: 10.1016/j.steroids.2011.02.039
![]() |
[130] |
Kraning-Rush C, Califano J, Reinhart-King C (2012) Cellular traction stresses increase with increasing metastatic potential. PLoS ONE 7: e32572. doi: 10.1371/journal.pone.0032572
![]() |
[131] | Trichet L, Le Digabel J, Hawkins R, et al. Evidence of a large-scale mechanosensing mechanism for cellular adaptation to substrate stiffness. Proc Natl Acad Sci U.S.A. 109: 6933–6938. |
[132] |
Peto R, Doll R, Buckley J (1981) Can dietary beta-carotene materially reduce human cancer rates? Nature 290: 201–208. doi: 10.1038/290201a0
![]() |
[133] | Shike M, Winawer S, Greenwald P, et al. (1990) Primary prevention of colorectal cancer. Bull World Health Organ 68: 337–385. |
[134] | Dorgan J, Schatzkin A (1991) Antioxidant micronutrients in cancer prevention. Hematol Oncol Clin North Am 5: 43–68. |
[135] |
Chlebowski R, Grosvenor M (1994) The scope of nutrition intervention trials with cancer-related endpoints. Cancer 74: 2734–2738. doi: 10.1002/1097-0142(19941101)74:9+<2734::AID-CNCR2820741824>3.0.CO;2-U
![]() |
[136] |
Ziegler R, Mayne S, Swanson C (1996) Nutrition and lung cancer. Cancer Causes Control 7: 157–177. doi: 10.1007/BF00115646
![]() |
[137] | Levander O (1997) Symposium: newly emerging viral diseases: what role for nutrition? J Nutr 127: 948S–950S. |
[138] | Willett W (1999) Convergence of philosophy and science: the Third International Congress on Vegetarian Nutrition. Am J Clin Nutr 70(suppl): 434S–438S. |
[139] | Meydani M (2000) Effect of functional food ingredients: vitamin E modulation of cardiovascular diseases and immune status in the elderly. Am J Clin Nutr 71(suppl): 1665S–1668S. |
[140] | Simopoulos A (2001) The Mediterranean diets: what is so special about the diet of Greece? The scientific experience. J Nutr 131: 3065S–3073S. |
[141] |
Rock C, Demark-Wahnefried W (2002) Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 20: 3302–3316. doi: 10.1200/JCO.2002.03.008
![]() |
[142] | Seifried H, McDonald S, Anderson D, et al. (2003) The antioxidant conundrum in cancer. Cancer Res 63: 4295–4298. |
[143] |
Männistö S, Smith-Warner S, Spiegelman D, et al. (2004) Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 13: 40–48. doi: 10.1158/1055-9965.EPI-038-3
![]() |
[144] | Fraga C (2007) Plant polyphenols: how to translate their in vitro antioxidant actions to in vivo conditions. Life 59: 308–315. |
[145] |
Kushi L, Doyle C, McCullough M, et al. (2012) American cancer society guidelines on nutrition and physical activity for cancer prevention. CA Cancer J Clin 62: 30–67. doi: 10.3322/caac.20140
![]() |
[146] |
Heinonen O, Albanes D, Huttunen J, et al. (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029–1035. doi: 10.1056/NEJM199404143301501
![]() |
[147] |
Hennekens C, Buring J, Manson J, et al. (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334: 1145–1149. doi: 10.1056/NEJM199605023341801
![]() |
[148] |
Omenn G, Goodman G, Thornquist M, et al. (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334: 1150–1155. doi: 10.1056/NEJM199605023341802
![]() |
[149] | Albanes D (1999) β-carotene and lung cancer: a case study. Am J Clin Nutr 69(suppl): 1345S–1350S. |
[150] |
Virtamo J, Albanes D, Huttunen J, et al. (2003) Incidence of cancer and mortality following α-tocopherol and β-carotene supplementation. JAMA 290: 476–485. doi: 10.1001/jama.290.4.476
![]() |
[151] | Sommer A, Vyas K (2012) A global clilnical view on vitamin A and carotenoids. Am J Clin Nutr 96(suppl): 1204–1206. |
[152] | Thompson I, Kristal A, Platz E (2014) Prevention of prostate cancer: outcomes of clinical trails and future opportunities. Am Soc Clin Oncol Educ Book 2014: e76–e80. |
[153] |
Virtamo J, Taylor P, Kontto J, et al (2014) Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year post-intervention follow-up of the alpha-tocopherol, beta-carotene cancer prevention (ATBC) study. Int J Cancer 135: 178–185. doi: 10.1002/ijc.28641
![]() |
[154] |
Yusuf S, Phil D, Dagenais G, et al. (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 342: 154–160. doi: 10.1056/NEJM200001203420302
![]() |
[155] | Devaraj S, Tang R, Adams-Huet B, et al. (2007) Effect of high-dose α-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr 86: 1392–1398. |
[156] | Sesso H, Buring J, Christen W, et al (2008) Vitamins E and C in the prevention of cardiovascular disease in men. JAMA 300: 2123–2133. |
[157] |
Brigelius-Flohe R, Galli F (2010) Vitamin E: a vitamin still awaiting the detection of its biological function. Mol Nutr Food Res 54: 583–587. doi: 10.1002/mnfr.201000091
![]() |
[158] | Schultz M, Leist M, Petrzika M, et al. (1995) Novel urinary metabolite of α-tocopherol, 2,5,7,8-tetramethyl-2(2'-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply. Am J Clin Nutr 62(suppl): 1527S–1534S. |
[159] |
Azzi A (2007) Molecular mechanism of α-tocopherol action. Free Radic Biol Med 43: 16–21. doi: 10.1016/j.freeradbiomed.2007.03.013
![]() |
[160] | Boddupalli S, Mein J, Lakkanna S, et al. (2012) Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins A, C, and E. Front Genet 3: 1–15. |
[161] |
Lü JM, Lin P, Yao Q, et al. (2010) Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med 14: 840–860. doi: 10.1111/j.1582-4934.2009.00897.x
![]() |
[162] | Apak R, Güçlü K, Özyürek M, et al. (2008) Mechanism of antioxidant capacity assays and the CUPRAC (cupric ion reducing antioxidant capacity) assay. Microch Acta 160: 413–419. |
[163] |
Özyürek M, Bektaşoğlu B, Güçlü K, et al. (2008) Simultaneous total antioxidant capacity assay of lipohilic and hydrophilic antioxidants in the same acetone-water solution containing 2% methyl-β-cyclodextrin using the cupric reducing antioxidant capacity (CUPRAC) method. Anal Chim ACTA 630: 28–39. doi: 10.1016/j.aca.2008.09.057
![]() |
[164] | McMurry J, (2004) Organic Chemistry, 6 Eds., Belmont, CA: Thompson Brooks/Cole, 403–405, 482–483, 486–487. |
[165] |
Dumas D, Muller S, Gouin F, et al. (1997) Membrane fluidity and oxygen diffusion in cholesterol enriched erythrocyte membrane. Arch Biochem Biophys 341: 34–39. doi: 10.1006/abbi.1997.9936
![]() |
[166] |
Cazzola R, Rondanelli M, Russo-Volpe S, et al. (2004) Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes. J Lipid Res 45: 1846–1851. doi: 10.1194/jlr.M300509-JLR200
![]() |
[167] | Madmani M, Yusaf S, Tamr A, et al. (2014) Coenzyme Q10 for heart failure (Review). Cochrane Database Syst Rev 2014. |
[168] | Watts G, Playford D, Croft K, et al. (2002). Coenzyme Q10 improves endothelial dysfunction of brachial artery in type II diabetes mellitus. Diabetologia 45:420–426. |
[169] |
DeCaprio A (1999) The toxicology of hydroquinone-relevance to occupational and environmental exposure. Crit Rev Toxicol 29: 283–330. doi: 10.1080/10408449991349221
![]() |
[170] | McMurry J, (2004) 17.11 Reactions of Phenols, In: Organic Chemistry, 6 Eds., Belmont, CA: Thompson Brooks/Cole, 618–619. |
[171] |
Takata J, Matsunage K, Karube Y (2002) Delivery systems for antioxidant nutrients. Toxicology 180: 183–193. doi: 10.1016/S0300-483X(02)00390-6
![]() |
[172] |
Pifer, J, Hearne F, Friedlander B, et al. (1986) Mortality study of men employed at a large chemical plant, 1972 through 1982. J Occup Med 28: 438–444. doi: 10.1097/00043764-198606000-00011
![]() |
[173] |
Pifer J, Hearne F, Swanson F (1995) Mortality study of employees engaged in the manufacture and use of hydroquinone. Int Arch Occup Environ Health 67: 267–280. doi: 10.1007/BF00409409
![]() |
[174] | Sterner J, Oglesby F, Anderson B (1947) Quinone vapors and their harmful effects. I Corneal and conjunctival injury. J Ind Hyg Toxicol 29: 60–73. |
[175] |
Carlson A, Brewer N (1953) Toxicity studies on hydroquinone. Proc Soc Exp Biol Med 84: 684–688. doi: 10.3181/00379727-84-20751
![]() |
[176] |
O'Donoghue J (2006) Hydroquinone and its analogues in dermatology-a risk-benefit viewpoint. J Cosmet Dermatol 5: 196–203. doi: 10.1111/j.1473-2165.2006.00253.x
![]() |
[177] | Nordlund J, Grimes P, Ortonne J (2006) The safety of hydroquinone. JEADV 20: 781–787. |
[178] |
Arndt K, Fitzpatrick T (1965) Topical use of hydroquinone as a depigmenting agent. JAMA 194: 965–967. doi: 10.1001/jama.1965.03090220021006
![]() |
[179] | Deisinger P, Hill T, English C (1996) Human exposure to naturally occurring hydroquinone. J Toxicol Env Health 47: 31–46. |
[180] |
Levitt J (2007) The safety of hydroquinone: a dermatologist's response to the 2006 Federal Register. J Am Acad Dermatol 57: 854–872. doi: 10.1016/j.jaad.2007.02.020
![]() |
[181] |
Marcus R, Sutin N (1985) Electron transfers in chemistry and biology. Biochim Biophys Acta 811: 265–322. doi: 10.1016/0304-4173(85)90014-X
![]() |
[182] | Dumas D, Latger V, Viriot M-L, et al. (1999) Membrane fluidity and oxygen diffusion in cholesterol-enriched endothelial cells. Clin Hemorheol Microcirc 21: 255–261. |
[183] | National Toxicology Program (1989) Toxicology and carcinogenesis studies of hydroquinone in F-344/N rats and B6C3F mice. NIH Publication : 90–2821. |
[184] |
Shibata MA, Hirose M, Tanaka H, et al. (1991) Induction of renal cell tumors in rats and mice, and enhancement of hepatocellular tumor development in mice after long-term hydroquinone treatment. Jap J Can Res 82: 1211–1219. doi: 10.1111/j.1349-7006.1991.tb01783.x
![]() |
[185] |
Poet T, Wu H, English J, et al (2004) Metabolic rate constants for hydroquinone in F344 rat and human liver isolated hepatocytes: application to a PBPK model. Toxicol Sci 82: 9–25. doi: 10.1093/toxsci/kfh229
![]() |
[186] |
MacDonald J (2004) Human carcinogenic risk evaluation, part IV: assessment of human risk of cancer from chemical exposure using a global weight-of-evidence approach. Toxicol Sci 82: 3–8. doi: 10.1093/toxsci/kfh189
![]() |
[187] | Food and Drug Administration (2015) Hydroquinone studies under the national toxicology program (NTP). 11/27/2015. Accessed 11/2016, Available from: http://www.fda/gov/About FDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm203112.htm. |
Organ specific autoimmune diseases | ||
Organ | Disease(s) | Self-Antigen |
Adrenal cells | Addison's disease | Cytochrome P-450 antigens |
Red blood cells | Autoimmune haemolitic anaemia | Red blood cell membrane proteins |
Platelets | Idiopathic thrombocytopaenic purpura | Platelet antigens |
Stomach | Pernicious anaemia | Gastric parietal cell antigens |
Small bowel | Coeliac sprue (gluten eneteropathy) | Transglutaminase |
Thyroid | Hashimoto's thyroiditis Grave's disease | Thyroid cell antigens Thyroid-stimulating hormone receptor |
Muscle | Myasthenia gravis | Acetylcholine receptors |
Pancreatic islets | Type 1 diabetes | Beta cell antigens |
Hepatocytes | Autoimmune hepatitis | Hepatocyte antigens (cytochrome P-450 2D6) |
Bile duct cells | Primary biliary cirrhosis | Intra-hepatic bile duct |
Heart | Rheumatic heart disease | Myocardial antigens |
Kidney/lung | Goodpasture's syndrome | Basement membrane antigens |
Systematic autoimmune diseases | ||
Disease(s) | Self-Antigen | |
Ankylosing sponkylitis | Vertebrae | |
Multiple sclerosis | Brain or white matter | |
Rheumatoid arthritis | Connective tissue, IgG | |
Systemic lupus erythematosus | DNA nuclear protein RBC and platelet membranes | |
Scleroderma | Nuclei, heart, lungs, gastrointestinal tract, kidney | |
Sjogren's syndrome | Salivary gland, liver, kidney, thyroid |
Organ specific autoimmune diseases | ||
Organ | Disease(s) | Self-Antigen |
Adrenal cells | Addison's disease | Cytochrome P-450 antigens |
Red blood cells | Autoimmune haemolitic anaemia | Red blood cell membrane proteins |
Platelets | Idiopathic thrombocytopaenic purpura | Platelet antigens |
Stomach | Pernicious anaemia | Gastric parietal cell antigens |
Small bowel | Coeliac sprue (gluten eneteropathy) | Transglutaminase |
Thyroid | Hashimoto's thyroiditis Grave's disease | Thyroid cell antigens Thyroid-stimulating hormone receptor |
Muscle | Myasthenia gravis | Acetylcholine receptors |
Pancreatic islets | Type 1 diabetes | Beta cell antigens |
Hepatocytes | Autoimmune hepatitis | Hepatocyte antigens (cytochrome P-450 2D6) |
Bile duct cells | Primary biliary cirrhosis | Intra-hepatic bile duct |
Heart | Rheumatic heart disease | Myocardial antigens |
Kidney/lung | Goodpasture's syndrome | Basement membrane antigens |
Systematic autoimmune diseases | ||
Disease(s) | Self-Antigen | |
Ankylosing sponkylitis | Vertebrae | |
Multiple sclerosis | Brain or white matter | |
Rheumatoid arthritis | Connective tissue, IgG | |
Systemic lupus erythematosus | DNA nuclear protein RBC and platelet membranes | |
Scleroderma | Nuclei, heart, lungs, gastrointestinal tract, kidney | |
Sjogren's syndrome | Salivary gland, liver, kidney, thyroid |